ACULYST

aculyst-logo

Aculyst was developed by healthcare leaders who recognized the value of the data model constructed over ten years and several iterations. The process of distilling the complexity of healthcare data into a pre-built data model that will serve all business and clinical units aims to crystalize KPI’s in user friendly dashboards. Integration of the data and the delivery of analytics is designed to serve business decision makers, in both service lines and nursing units as well as finance executives... . Aculyst delivers enterprise level solutions that create daily awareness of trends and variances you can’t see today. By linking operations, finance, quality and staffing, executives and managers can now intervene with confidence on cost over runs, avoid bottlenecks and increase patient satisfaction and safety with increased through put.

#SimilarOrganizations #People #Website #More

ACULYST

Social Links:

Industry:
Analytics Health Care Information Technology Software

Founded:
2016-01-01

Address:
Plainfield, Illinois, United States

Country:
United States

Website Url:
http://www.aculyst.com

Total Employee:
51+

Status:
Active

Contact:
908 791 3380

Total Funding:
483.36 K USD

Technology used in webpage:
LeaseWeb


Similar Organizations

datazymes-logo

DataZymes

Catalyzing Innovation in Pharma with Data-driven Digital Products

seratis-logo

Seratis

Communication for healthcare providers

Founder


asha-saxena_image

Asha Saxena

Official Site Inspections

http://www.aculyst.com

Unable to get host informations!!!

Loading ...

More informations about "Aculyst"

アキュリスファーマ株式会社

ACULYS News Releases are issued to provide press journalists with the information related to our company. In some instances, information on products or drug candidates under development may be included, but it is not intended for …See details»

Company | Aculys Pharma, Inc.

Aculys Pharma, Inc. was founded as Japan’s first biopharma company based on the philosophy of “Catalyst to Access”. Our goal is to become the leading provider of innovations for …See details»

Aculys Pharma, Inc.

Nov 24, 2023 Jul 22, 2024 Aculys Pharma Completes Patient Enrollment for Phase 3 Clinical Trial on Pitolisant in Patients with Narcolepsy; Apr 01, 2024 Aculys Pharma Announces …See details»

Aculys Pharma - Crunchbase Company Profile & Funding

Aculys Pharma closed its last funding round on Mar 28, 2022 from a Series B round. Who are Aculys Pharma 's competitors? Alternatives and possible competitors to Aculys Pharma may …See details»

Aculys Company Profile 2024: Valuation, Funding & Investors

Aculys General Information Description. Developer of therapeutic medicines designed to cure hypersomnia. The company creates drugs that are aimed to help patients who are suffering …See details»

Aculys Pharma - Funding, Financials, Valuation & Investors

Aculys Pharma is a pharmaceutical company that develops drugs and innovative medical treatments for neurological and psychiatric disorders. ... How much funding has this …See details»

Aculyst - Crunchbase Company Profile & Funding

Aculyst was developed by healthcare leaders who recognized the value of the data model constructed over ten years and several iterations. The process of distilling the complexity of …See details»

ACULYS PHARMA, INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for ACULYS PHARMA, INC. of MINATO-KU, TOKYO. Get the latest business insights from Dun & …See details»

Our Business - Aculys Pharma, Inc.

Drug loss, from the underdevelopment of new drugs in Japan Around the world, startup companies play an increasingly important role in the development of new drugs, responsible for discovering and developing approximately 80% of new …See details»

Aculys - Catalys Pacific

Aculys Pharma is a private biopharmaceutical company focused on the development and commercialization of innovations in the therapeutic area of CNS for the greater Japan region. It was founded by Catalys Pacific to address the …See details»

Aculys - HBM Partners

Aculys Pharma is a biopharmaceutical company focused on the development and commercialization of innovations in the fields of neurology and psychiatry. The proceeds of the …See details»

Portfolio details - j-vgi.co.jp

Aculys Pharma, Inc. Promoting the development and commercialization of innovative new drugs in the field of neurological and psychiatric diseases; in-licensing, development, and marketing …See details»

Aculys Pharma - Contacts, Employees, Board Members

Organization. Aculys Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Number of …See details»

アキュリスファーマ株式会社の会社情報と資金調達 | NIKKEI …

【NIKKEI COMPASS】アキュリスファーマ株式会社は、神経・精神疾患領域における新薬の開発と商業化を推進するバイオベンチャー企業。 同社は ...See details»

Company | アキュリスファーマ株式会社

現在はCalluna PharmaおよびAM-Pharmaの取締役会会長を務め、Novaremed、Merz Therapeutics、Aculys、Alectorの取締役を兼任。以前は、Arvelle Therapeuticsの創設者、社 …See details»

アキュリスファーマはてんかん発作に対する抗けいれん薬ジアゼ …

Aculys was formed in 2021 to catalyze innovative treatments for neurological and psychiatric disorders. We are committed to shortening the drug lag in Japan by developing and …See details»

アキュリスファーマがてんかん発作に関わる社会課題の解決を目 …

Jul 4, 2022 神経・精神疾患領域における革新的な新薬の開発と商業化を推進するアキュリスファーマ株式会社(本社:東京都港区、代表取締役社長兼ceo:綱場 一成、以下「アキュリス …See details»

Aculys Pharma Closes US$60 Million Series A Financing Led by …

Oct 28, 2021 Aculys Pharma, Inc. (“Aculys Pharma”), a new biopharmaceutical company focused on the development and commercialization of new innovative drugs in the fields of …See details»

Aculys Pharma Initiates Phase 3 Trial of Pitolisant Treating Patients ...

Jan 24, 2023 Aculys Pharma is a clinical stage biopharmaceutical company focused on the commercialization of neurology innovations for patients in Japan. Aculys was formed in 2021 …See details»

Aculys Pharma joins the Sleep Services Consortium of Japan

Tokyo, Japan, March2, 2023 — Aculys Pharma, Inc. (“Aculys”), a clinical stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions …See details»

linkstock.net © 2022. All rights reserved